Cohbar (OTCMKTS:CWBR) released its earnings results on Tuesday. The company reported ($0.07) earnings per share (EPS) for the quarter, Morningstar.com reports.
Shares of CWBR opened at $2.52 on Thursday. Cohbar has a 1 year low of $2.11 and a 1 year high of $10.79.
An institutional investor recently raised its position in Cohbar stock. Geode Capital Management LLC raised its stake in shares of Cohbar Inc (OTCMKTS:CWBR) by 4.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 271,648 shares of the company’s stock after buying an additional 10,842 shares during the quarter. Geode Capital Management LLC owned about 0.64% of Cohbar worth $844,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
ILLEGAL ACTIVITY NOTICE: This piece was first reported by Equities Focus and is the property of of Equities Focus. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://www.equitiesfocus.com/2019/05/09/cohbar-cwbr-issues-quarterly-earnings-results.html.
CohBar, Inc, a biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. Its lead MBT drug candidates include CB4209 and CB4211, which are in IND-enabling studies for the treatment of fatty liver disease, non-alcoholic steatohepatitis, obesity, and type 2 diabetes mellitus.
Featured Story: Institutional Investors
Receive News & Ratings for Cohbar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cohbar and related companies with MarketBeat.com's FREE daily email newsletter.